| Characteristics | Level | N (%) |
| Demographic characteristics |
|
|
| Age | < 20 | 25 (11.2) |
|
| 20 - 30 | 69 (30.9) |
|
| 31 - 40 | 36 (16.1) |
|
| 41 - 50 | 31 (13.9) |
|
| 51 - 60 | 29 (13) |
|
| <60 | 33 (14.8) |
| Gender | Male | 84 (37.7) |
|
| Female | 139 (62.3) |
| Ethnicity | Indigenous | 103 (46.2) |
|
| Non Indigenous | 120 (53.8) |
| Area | Urban | 98 (43.9) |
|
| Rural | 125 (56.1) |
| Clinical characteristics |
|
|
| Treatment history | New | 82 (36.8) |
|
| Previously treated | 141 (63.2) |
| TB symptoms | Cough | 218 (97.7) |
|
| Fever | 182 (81.6) |
|
| Weight loss | 158 (70.8) |
|
| Night sweat | 116 (74.4) |
| Radiological Characteristics |
|
|
| X-ray findings | Cavities | 86 (38.6) |
|
| No Cavities | 137 (61.4) |
| Mycobacteriology characteristics |
|
|
| Smear results |
|
|
| ZN staining | Positive | 85 (38.1) |
|
| Negative | 138 (61.9) |
| Flurochrome staining | Positive | 105 (47.1) |
|
| Negative | 118 (52.9) |
| Culture on LJ media | Positive | 102 (45.7) |
|
| Negative | 121 (54.3) |
| Drug susceptibility Testing | Resistance to any one drug (SM + INH + RIF + EMB) | 39 (38.2) |
|
| MDR-TB | 12 (11.8) |